RalphLewisKramerMD

PubMed

• 130 citations
  Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors o...
  Yuval Yaron, Michele Cherry, Ralph L. Kramer, Joseph E. O’Brien, Mordechai Hallak, Mark P. Johnson, Mark I. Evans> ;American Journal of Obstetrics and Gynecology. 1999 Oct 1
• 5 citations
  Prenatal evaluation of a de novo X;9 translocation.
  Baruch Feldman, Ralph L. Kramer, Salah A.D. Ebrahim, Dayna J. Wolff, Mark I. Evans> ;American Journal of Medical Genetics. 1999 Aug 27
• 6 citations
  Ontogeny of recurrent hydrocephalus: presentation in three fetuses in one consanguineous family.
  Teresa B. Brady, Ralph L. Kramer, Faisal Qureshi, Baruch Feldman, William J. Kupsky, Mark P. Johnson, Mark I. Evans> ;Fetal Diagnosis and Therapy. 1999 Jul 1
• 5 citations
  Amnioinfusion in the Evaluation of Fetal Obstructive Uropathy: The Effect of Antibiotic Prophylaxis on Complication Rates
  Baruch Feldman, Sonia S. Hassan, Ralph L. Kramer, Stefanie Kasperski, Mark I. Evans, Mark P. Johnson> ;Fetal Diagnosis and Therapy. 1999 Jun 11
• 9 citations
  Prenatal diagnosis of 46,XY/46,XX mosaicism: A case report†
  Yuval Yaron, Baruch Feldman, Ralph L. Kramer, Stefanie B. Kasperski, Trieu Vo, Gerald L. Feldman, Mark P. Johnson, Mark I. Evans, Salah A.D. Ebrahim> ;American Journal of Medical Genetics. 1999 May 7
• 84 citations
  Multifetal pregnancy reductions of triplets to twins: Comparison with nonreduced triplets and twins
  Yuval Yaron, Peter K. Bryant-Greenwood, Neha Dave, Julie Moldenhauer, Ralph L. Kramer, Mark P. Johnson, Mark I. Evans> ;American Journal of Obstetrics and Gynecology. 1999 May 1
• 15 citations
  Molecular cytogenetic analysis of a de novo 5q31q33 deletion associated multiple congenital anomalies: case report.
  Ralph L. Kramer, Baruch Feldman, Salah A.D. Ebrahim, Stefanie B. Kasperski, Mark P. Johnson, Mark I. Evans> ;American Journal of Medical Genetics. 1999 Jan 15
• 1 citations
  2nd-Trimester Maternal Serum Marker Results Are Not Altered by Delayed Analysis
  Baruch Feldman, Elena Dvorin, Tracy Phillips, Ralph L. Kramer, Mark P. Johnson, Mark I. Evans> ;Fetal Diagnosis and Therapy. 1998 Nov 18
• 7 citations
  Age-specific variation in aneuploidy incidence among biochemical screening programs
  Andrew I. Sokol, Ralph L. Kramer, Yuval Yaron, Joseph E. O’Brien, Françoise Muller, Mark P. Johnson, Mark I. Evans> ;American Journal of Obstetrics and Gynecology. 1998 Oct 1
• 37 citations
  Determinants of parental decisions after the prenatal diagnosis of Down syndrome
  Ralph L. Kramer, Robert K. Jarve, Yuval Yaron, Mark P. Johnson, Jenifer Lampinen, Stefanie B. Kasperski, Mark I. Evans> ;American Journal of Medical Genetics. 1998 Sep 23
• 28 citations
  Selective termination and elective reduction in twin pregnancies: 10 years experience at a single centre.
  Yuval Yaron, K D Johnson, P K Bryant-Greenwood, Ralph L. Kramer, Mark P. Johnson, M. I. Evans> ;Human Reproduction. 1998 Aug 1
• 1 citations
  Pastoral Care Utilization among Women Electing Pregnancy Termination for Fetal Anomalies
  Teresa B. Brady, Sue Lidums, Yuval Yaron, Mark I. Evans, Mark P. Johnson, Ralph L. Kramer> ;Fetal Diagnosis and Therapy. 1998 Jun 2
• 25 citations
  Prenatal diagnosis of cloacal dysgenesis sequence: differential diagnosis from other forms of fetal obstructive uropathy.
  Faisal Qureshi, Suzanne M. Jacques, Yuval Yaron, Ralph L. Kramer, Mark I. Evans, Mark P. Johnson> ;Fetal Diagnosis and Therapy. 1998 Mar 1
• 34 citations
  Fetal gender impact on multiple-marker screening results.
  Lisa B. Bazzett, Yuval Yaron, Joseph E. O'Brien, Gregory Critchfield, Ralph L. Kramer, Mazin Ayoub, Mark P. Johnson, Mark I. Evans> ;American Journal of Medical Genetics. 1998 Apr 13
• 14 citations
  WHAT ARE THE ETHICAL AND TECHNICAL PROBLEMS ASSOCIATED WITH MULTIFETAL PREGNANCY REDUCTION
  Mark I. Evans, Ralph L. Kramer, Yuval Yaron, Arie Drugan, Mark P. Johnson> ;Clinical Obstetrics and Gynecology. 1998 Mar 1
• 18 citations
  10 Multifetal pregnancy reduction
  Mark I. Evans, Roderick F. Hume, Yuval Yaron, Ralph L. Kramer, Mark P. Johnson> ;Bailliere's Clinical Obstetrics and Gynaecology. 1998 Mar 1
• 14 citations
  Effect of adjustment of maternal serum α-fetoprotein levels in insulin-dependent diabetes mellitus
  Ralph L. Kramer, Yuval Yaron, Joseph E. O'Brien, Gregory Critchfield, Melissa A. Ayoub, Mark P. Johnson, C.R. Qualls, M. I. Evans> ;American Journal of Medical Genetics. 1998 Jan 13
• 6 citations
  No Effect of Fetal Sex on Amniotic Fluid Alpha-Fetoprotein
  Arie Drugan, Yuval Yaron, June Murphy, Saleh A.D. Ebrahim, Ralph L. Kramer, Mark P. Johnson, Mark I. Evans> ;Fetal Diagnosis and Therapy. 1997 Sep 1
• 13 citations
  Concordance for cloacal dysgenesis.
  Ralph L. Kramer, Mark P. Johnson, Faisal Qureshi, Suzanne M. Jacques, Yuval Yaron, MI Evans> ;Fetal Diagnosis and Therapy. 1997 Sep 1
• 16 citations
  Differences in measurements of the atria of the lateral ventricle: Does gender matter?
  Ralph L. Kramer, Yuval Yaron, Mark P. Johnson, Mark I. Evans, Marjorie C. Treadwell, Honor M. Wolf> ;Fetal Diagnosis and Therapy. 1997 Jul 1
• 33 citations
  Trisomy 21 placentas: histopathological and immunohistochemical findings using proliferating cell nuclear antigen.
  Faisal Qureshi, Suzanne M. Jacques, Mark P. Johnson, Roderick F. Hume, Ralph L. Kramer, Yuval Yaron, Mark I. Evans> ;Fetal Diagnosis and Therapy. 1997 Jul 1
• 7 citations
  GENE THERAPY: Is the Future Here Yet?
  Yuval Yaron, Ralph L. Kramer, Mark P. Johnson, Mark I. Evans> ;Obstetrics and Gynecology Clinics of North America. 1997 Mar 1
• Join now to see all